The next place to look is in the gut, where GLP-1 can slow gastric emptying which can often make you feel full longer than you normally would, which can delay periods between feeding as you are less likely to eat again if you feel full longer
This approach has been successfully applied in developing long-acting insulin analogs like insulin detemir and insulin glargine
Phase 3 ACHIEVE-1 trial results for orforglipron, as discussed by Rosenstock and colleagues, demonstrated that this once-daily oral small molecule GLP-1 achieved statistically significant reductions in HbA1c (1.3% to 1.6% from a baseline of 8.0%) compared to placebo in adults with type 2 diabetes
By the 1940s glucagon was being widely used for this purpose in Europe and North America (Unger)
GHRP and GHRH: What They Are, Key Differences, and Why We Often Use Them Together Peptide therapy has emerged as one of the most powerful and precise ways to support health, longevity, and optimal performance